News Article

August 17 2012

A team of researchers led by Kojo Elenitoba-Johnson, M.D., Henry Clay Bryant Professor of Pathology, and Mark Kiel, M.D., Ph.D., a resident in Pathology, and Thirunavukkarasu Velusamy, Ph.D., a post-doctoral fellow in the Elenitoba-Johnson Laboratory, have  identified among others, the most frequent acquired genetic mutation in the most common form of malignant lymphoma in the spleen. This work, "Whole Genome Sequencing Identifies Recurrent NOTCH2 Mutations in Splenic Marginal Zone Lymphoma" is reported this week in the on-line edition of the Journal of Experimental Medicine.